应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
00460 四环医药
休市中 04-19 16:08:35
0.510
+0.000
0.00%
最高
0.520
最低
0.500
成交量
648.60万
今开
0.520
昨收
0.510
日振幅
3.92%
总市值
47.58亿
流通市值
47.58亿
总股本
93.30亿
成交额
330.24万
换手率
0.07%
流通股本
93.30亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
南向资金4月16日净买入四环医药402.60万股 连续5日增持
自选股智能写手 · 04-17
南向资金4月16日净买入四环医药402.60万股 连续5日增持
南向资金4月12日净买入四环医药41.30万股 连续3日增持
自选股智能写手 · 04-15
南向资金4月12日净买入四环医药41.30万股 连续3日增持
四环医药04月12日遭主力抛售235万元 环比增加298.31%
自选股智能写手 · 04-12
四环医药04月12日遭主力抛售235万元 环比增加298.31%
四环医药(00460)出现大手卖出290万股,成交价$0.52,涉资150.8万
阿斯达克财经 · 04-12
四环医药(00460)出现大手卖出290万股,成交价$0.52,涉资150.8万
港股异动 | 四环医药(00460)涨超5% 23年公司医美收益大幅增长 机构认为我国医美渗透率仍有较大提升空间
智通财经 · 04-10
港股异动 | 四环医药(00460)涨超5% 23年公司医美收益大幅增长 机构认为我国医美渗透率仍有较大提升空间
四环医药(00460)上涨5.77%,报0.55元/股
金融界 · 04-10
四环医药(00460)上涨5.77%,报0.55元/股
四环医药盘中异动 快速拉升5.77%报0.550港元
自选股智能写手 · 04-10
四环医药盘中异动 快速拉升5.77%报0.550港元
四环医药(00460):医美业绩强势爆发 盈利拐点向上撬动估值逻辑
智通财经 · 04-10
四环医药(00460):医美业绩强势爆发 盈利拐点向上撬动估值逻辑
四环医药盘中异动 股价大跌5.45%
自选股智能写手 · 04-05
四环医药盘中异动 股价大跌5.45%
医美收益翻倍涨 四环医药去年总收益18.61亿元
贝壳财经 · 03-29
医美收益翻倍涨 四环医药去年总收益18.61亿元
四环医药(00460)下跌5.26%,报0.54元/股
金融界 · 03-28
四环医药(00460)下跌5.26%,报0.54元/股
四环医药盘中异动 股价大跌5.26%报0.540港元
自选股智能写手 · 03-28
四环医药盘中异动 股价大跌5.26%报0.540港元
四环医药(00460)股价下跌5.263%,现价港币$0.54
阿斯达克财经 · 03-28
四环医药(00460)股价下跌5.263%,现价港币$0.54
四环医药发布2023年度业绩 总收益达18.605亿元
新浪港股 · 03-28
四环医药发布2023年度业绩 总收益达18.605亿元
四环医药(00460)发布2023年度业绩,总收益达18.605亿元,医美分部收益同比上升约200.3%
智通财经 · 03-28
四环医药(00460)发布2023年度业绩,总收益达18.605亿元,医美分部收益同比上升约200.3%
《公司业绩》四环医药(00460.HK)全年亏损收窄至5,401.7万元人民币
阿斯达克财经 · 03-28
《公司业绩》四环医药(00460.HK)全年亏损收窄至5,401.7万元人民币
南向资金3月25日净买入四环医药81.90万股 连续3日增持
自选股智能写手 · 03-26
南向资金3月25日净买入四环医药81.90万股 连续3日增持
四环医药03月25日遭主力抛售123万元 环比增加459.09%
自选股智能写手 · 03-25
四环医药03月25日遭主力抛售123万元 环比增加459.09%
加载更多
公司概况
公司名称:
四环医药
所属市场:
SEHK
上市日期:
--
主营业务:
四环医药控股集团有限公司是一家从事药品业务的香港投资控股公司。该公司主要在中国从事研发、制造及销售药品。其产品覆盖心脑血管、中枢神经系统、新陈代谢、肿瘤及抗感染领域。其心脑血管产品包括克林澳、安捷利及欧迪美等。其非心脑血管产品包括仁澳、甲硝唑及罗沙替丁等。
发行价格:
--
{"stockData":{"symbol":"00460","market":"HK","secType":"STK","nameCN":"四环医药","latestPrice":0.51,"timestamp":1713514115026,"preClose":0.51,"halted":0,"volume":6486000,"delay":0,"floatShares":9329999206,"shares":9329999206,"eps":-0.006274192,"marketStatus":"休市中","marketStatusCode":7,"change":0,"latestTime":"04-19 16:08:35","open":0.52,"high":0.52,"low":0.5,"amount":3302380,"amplitude":0.039216,"askPrice":0.51,"askSize":27000,"bidPrice":0.5,"bidSize":5620000,"shortable":3,"etf":0,"ttmEps":-0.0062741921185352255,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1713749400000},"adr":0,"adjPreClose":0.51,"dividendRate":0.067637,"openAndCloseTimeList":[[1713490200000,1713499200000],[1713502800000,1713513600000]],"volumeRatio":0.8313253012197367,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/00460","defaultTab":"news","newsList":[{"id":"2428733489","title":"南向资金4月16日净买入四环医药402.60万股 连续5日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2428733489","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428733489?lang=zh_cn&edition=full","pubTime":"2024-04-17 09:31","pubTimestamp":1713317473,"startTime":"0","endTime":"0","summary":"4月16日, 南向资金增持四环医药402.60万股,连续5日增持。截止当日收盘,港股通共持有四环医药86686.50万股,占流通股9.28%。四环医药近5个交易日下跌3.85%,港股通累计增持948.00万股;近20个交易日下跌15.25%,港股通累计增持1699.70万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404170947398b2cb14a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404170947398b2cb14a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427609420","title":"南向资金4月12日净买入四环医药41.30万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2427609420","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427609420?lang=zh_cn&edition=full","pubTime":"2024-04-15 09:31","pubTimestamp":1713144669,"startTime":"0","endTime":"0","summary":"4月12日, 南向资金增持四环医药41.30万股,连续3日增持。截止当日收盘,港股通共持有四环医药86227.70万股,占流通股9.24%。港股通增持金额前五个股分别为中国石油股份、中国移动、中国银行、兖矿能源、中通快递-W。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404150944308b23b5f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404150944308b23b5f8&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426270910","title":"四环医药04月12日遭主力抛售235万元 环比增加298.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426270910","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426270910?lang=zh_cn&edition=full","pubTime":"2024-04-12 16:16","pubTimestamp":1712909763,"startTime":"0","endTime":"0","summary":"04月12日, 四环医药股价跌3.70%,报收0.52元,成交金额651万元,换手率0.13%,振幅3.70%,量比1.18。四环医药今日主力资金净流出235万元,上一交易日主力净流出59万元,今日环比增加298.31%。该股主力净额占比0.05%,港股市场排名2532/2628。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240412161657876d9ebd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240412161657876d9ebd&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426277564","title":"四环医药(00460)出现大手卖出290万股,成交价$0.52,涉资150.8万","url":"https://stock-news.laohu8.com/highlight/detail?id=2426277564","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2426277564?lang=zh_cn&edition=full","pubTime":"2024-04-12 15:55","pubTimestamp":1712908500,"startTime":"0","endTime":"0","summary":"[大手成交]四环医药(00460)在下午03:55出现大手卖出,成交量为290万,成交价为港币$0.52,涉资150.8万。至目前为止,股价跌3.704%,今日最高价为$0.54,而最低价为$0.52,总成交量为1.077千万股,总成交金额港币$569.408万。","market":"other","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180815142908927_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180815142908927_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAV2404123307/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2426101000","title":"港股异动 | 四环医药(00460)涨超5% 23年公司医美收益大幅增长 机构认为我国医美渗透率仍有较大提升空间","url":"https://stock-news.laohu8.com/highlight/detail?id=2426101000","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2426101000?lang=zh_cn&edition=full","pubTime":"2024-04-10 10:15","pubTimestamp":1712715302,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,四环医药涨超5%,截止发稿涨5.77%,报0.55港元,成交额294万港元。华泰证券表示,23年医美行业新品获批阶段性空窗期,叠加需求较弱,倒逼下游机构“以价换量”,同质化较强/成熟度较高/价格带透明的产品易陷入低价引流困境,预计24年新品获批数量相较23年增加,对于终端需求有提振作用。中长期来看,我国医美渗透率仍有较大提升空间。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1100407.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2426104937","title":"四环医药(00460)上涨5.77%,报0.55元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2426104937","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2426104937?lang=zh_cn&edition=full","pubTime":"2024-04-10 10:02","pubTimestamp":1712714573,"startTime":"0","endTime":"0","summary":"4月10日,四环医药(00460)盘中上涨5.77%,截至10:02,报0.55元/股,成交284.52万元。四环医药控股集团有限公司是中国处方药市场的领先制药企业,主要业务为生产和销售心脑血管处方药物,自2007年起一直是全国最大的心脑血管处方药物供应商。公司的关键经营数据包括独特的销售模式、全国覆盖的销售网络、多元化的产品组合以及强大的研发能力。截至2023年年报,四环医药营业总收入18.61亿元、净利润-5401.7万元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/04/10100240176383.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2426101173","title":"四环医药盘中异动 快速拉升5.77%报0.550港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426101173","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426101173?lang=zh_cn&edition=full","pubTime":"2024-04-10 10:02","pubTimestamp":1712714568,"startTime":"0","endTime":"0","summary":"2024年04月10日早盘10时02分,四环医药股票出现波动,股价急速上涨5.77%。截至发稿,该股报0.550港元/股,成交量528.3万股,换手率0.06%,振幅5.77%。资金方面,该股资金流入255.584万港元,流出14.726万港元。四环医药股票所在的药品行业中,整体跌幅为0.09%。其相关个股中,四环医药、中生联合、东阳光长江药业涨幅较大,振幅较大的相关个股有三爱健康集团、中生联合、联康生物科技集团,振幅分别为17.65%、14.04%、8.60%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404101002497a51c25d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404101002497a51c25d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426108946","title":"四环医药(00460):医美业绩强势爆发 盈利拐点向上撬动估值逻辑","url":"https://stock-news.laohu8.com/highlight/detail?id=2426108946","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2426108946?lang=zh_cn&edition=full","pubTime":"2024-04-10 09:15","pubTimestamp":1712711750,"startTime":"0","endTime":"0","summary":"根据国内报告,2022年中国医美手术收入占比48%,非手术收入占比52%。在生产端,四环医药产品覆盖轻医美的基础类别,落成两个生产基地及7条生产线,确保部分产品获批后能快速实现产业化发展。随着产品储备丰富,四环医药医美板块有望持续加码高景气赛道,业绩增长有望延续。就行业贝塔来看,四环医药将享受医美+医药行业增长红利。随着医美平台化价值释放,四环医药将持续攫取轻医美市场的规模红利。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1100373.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2425022309","title":"四环医药盘中异动 股价大跌5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2425022309","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2425022309?lang=zh_cn&edition=full","pubTime":"2024-04-05 11:05","pubTimestamp":1712286333,"startTime":"0","endTime":"0","summary":"2024年04月05日早盘11时05分,四环医药股票出现异动,股价急速跳水5.45%。截至发稿,该股报0.520港元/股,成交量152.2万股,换手率0.02%,振幅3.64%。资金方面,该股资金流入16.71万港元,流出64.103万港元。四环医药股票所在的药品行业中,整体跌幅为0.22%。其相关个股中,前海健康、三爱健康集团、天大药业涨幅较大,振幅较大的相关个股有三爱健康集团、康龙化成、复星医药,振幅分别为16.22%、9.71%、8.85%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240405110533791ed43d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240405110533791ed43d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2423103923","title":"医美收益翻倍涨 四环医药去年总收益18.61亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2423103923","media":"贝壳财经","top":-1,"share":"https://www.laohu8.com/m/news/2423103923?lang=zh_cn&edition=full","pubTime":"2024-03-29 09:47","pubTimestamp":1711676854,"startTime":"0","endTime":"0","summary":"报告期内,公司总收益为18.61亿元,同比下降约14.7%;公司拥有人应占亏损约5402万元,同比增长97.18%;期内亏损为2.58亿元,去年同期亏损22.85亿元。分板块看,医美产品的收益为4.499亿元,同比上升约200.3%。仿制药的销售收益13.98亿元,同比下降29.0%。四环医药表示,主要由于受到集采降价以及部分产品新纳入重点监控目录带来的部分仿制药的价格和销量均出现下滑的影响。创新药业务及其他业务收益约为1180万元,同比下降80.6%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032909484287c2f436&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032909484287c2f436&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422133515","title":"四环医药(00460)下跌5.26%,报0.54元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2422133515","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2422133515?lang=zh_cn&edition=full","pubTime":"2024-03-28 14:11","pubTimestamp":1711606312,"startTime":"0","endTime":"0","summary":"3月28日,四环医药(00460)盘中下跌5.26%,截至14:11,报0.54元/股,成交654.25万元。四环医药控股集团有限公司是中国处方药市场的领先制药企业,主要业务为生产和销售心脑血管处方药物,自2007年起一直是全国最大的心脑血管处方药物供应商。公司的关键经营数据包括独特的销售模式、全国覆盖的销售网络、多元化的产品组合以及强大的研发能力。截至2023年中报,四环医药营业总收入10.56亿元、净利润-4964.4万元。3月28日,四环医药披露2023财年年报。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/03/28141140033337.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2422184032","title":"四环医药盘中异动 股价大跌5.26%报0.540港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422184032","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422184032?lang=zh_cn&edition=full","pubTime":"2024-03-28 13:09","pubTimestamp":1711602553,"startTime":"0","endTime":"0","summary":"2024年03月28日下午盘13时09分,四环医药股票出现波动,股价大幅跳水5.26%。截至发稿,该股报0.540港元/股,成交量572.8万股,换手率0.06%,振幅5.26%。资金方面,该股资金流入35.866万港元,流出253.424万港元。四环医药股票所在的药品行业中,整体涨幅为0.01%。截至2024年2月29日,渼颜空间的销售渠道已覆盖全国累计350余个城市及超过4700家医疗美容机构,对头部500医美机构的覆盖率达到100%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240328130914791d72ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240328130914791d72ad&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422182272","title":"四环医药(00460)股价下跌5.263%,现价港币$0.54","url":"https://stock-news.laohu8.com/highlight/detail?id=2422182272","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2422182272?lang=zh_cn&edition=full","pubTime":"2024-03-28 13:09","pubTimestamp":1711602540,"startTime":"0","endTime":"0","summary":"[下跌股]四环医药(00460) 股价在下午01:09比前收市价下跌5.263%,现股价为港币$0.54。至目前为止,今日最高价为$0.57,而最低价为$0.54。总成交量为572.8万股,总成交金额为港币$318.124万。","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180205152747204_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180205152747204_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2403282170/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2422181275","title":"四环医药发布2023年度业绩 总收益达18.605亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422181275","media":"新浪港股","top":-1,"share":"https://www.laohu8.com/m/news/2422181275?lang=zh_cn&edition=full","pubTime":"2024-03-28 12:52","pubTimestamp":1711601532,"startTime":"0","endTime":"0","summary":"四环医药(00460)发布截至2023年12月31日止年度业绩,总收益约为人民币18.605亿元;其中收入的变化,来自医美产品的收益为人民币4.499亿元,同比上升约200.3%,主要由于伴随国内疫情管控的全面放开以及消费需求的逐步回暖,集团旗下医美平台渼颜空间通过渠道库存的清理、与多家医美机构实现战略合作以及大力推广营销战略3.0版本升级所取得阶段性的成功,成功实现了医美销售收入的大幅回升。\n\n股市回暖,抄底炒股先开户!智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-03-28/doc-inapvxxw5738540.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-03-28/doc-inapvxxw5738540.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2422181146","title":"四环医药(00460)发布2023年度业绩,总收益达18.605亿元,医美分部收益同比上升约200.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422181146","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2422181146?lang=zh_cn&edition=full","pubTime":"2024-03-28 12:47","pubTimestamp":1711601226,"startTime":"0","endTime":"0","summary":"智通财经APP讯,四环医药 发布截至2023年12月31日止年度业绩,总收益约为人民币18.605亿元;其中收入的变化,来自医美产品的收益为人民币4.499亿元,同比上升约200.3%,主要由于伴随国内疫情管控的全面放开以及消费需求的逐步回暖,集团旗下医美平台渼颜空间通过渠道库存的清理、与多家医美机构实现战略合作以及大力推广营销战略3.0版本升级所取得阶段性的成功,成功实现了医美销售收入的大幅回升。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1094510.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2422181180","title":"《公司业绩》四环医药(00460.HK)全年亏损收窄至5,401.7万元人民币","url":"https://stock-news.laohu8.com/highlight/detail?id=2422181180","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2422181180?lang=zh_cn&edition=full","pubTime":"2024-03-28 12:22","pubTimestamp":1711599720,"startTime":"0","endTime":"0","summary":"四环医药公布截至去年12月底止全年业绩,持续经营业务营业额18.61亿元人民币(下同),按年跌14.7%。亏损收窄至5,401.7万元,上年同期蚀19.15亿元;每股亏损0.58分。去年同期派末期息3.2分人民币。(港股报价延迟最少十五分钟。沽空资料截至 2024-03-27 16:25。)过往派息公布日期派息事项派息内容2023/08/29中期业绩无派息2023/03/24末期业绩普通股息:人民币 0.0320﹙相当于港元 0.0370﹚2022/08/30中期业绩普通股息:人民币 0.0010﹙相当于港元 0.0010﹚2022/08/30中期业绩特别股息:人民币 0.0320﹙相当于港元 0.0360﹚AASTOCKS新闻","market":"fut","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20220413154446706_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20220413154446706_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1338293/latest-news/AAFN","is_publish_highlight":false,"gpt_icon":0},{"id":"2422068309","title":"南向资金3月25日净买入四环医药81.90万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2422068309","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422068309?lang=zh_cn&edition=full","pubTime":"2024-03-26 09:31","pubTimestamp":1711416671,"startTime":"0","endTime":"0","summary":"3月25日, 南向资金增持四环医药81.90万股,连续3日增持。截止当日收盘,港股通共持有四环医药84845.40万股,占流通股9.08%。四环医药近5个交易日下跌3.45%,港股通累计增持674.70万股;近20个交易日下跌3.45%,港股通累计增持1025.30万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032609450987b55910&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032609450987b55910&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422624655","title":"四环医药03月25日遭主力抛售123万元 环比增加459.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422624655","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422624655?lang=zh_cn&edition=full","pubTime":"2024-03-25 16:15","pubTimestamp":1711354556,"startTime":"0","endTime":"0","summary":"03月25日, 四环医药股价跌1.75%,报收0.56元,成交金额349万元,换手率0.07%,振幅5.26%,量比0.78。四环医药今日主力资金净流出123万元,连续3日净流出,上一交易日主力净流出22万元,今日环比增加459.09%。近一年数据显示,该股主力连续3日净流出后,次日下跌概率为57.14%,平均跌幅为2.20%。该股近5个交易日下跌3.45%,主力资金累计净流出120万元;近20日主力资金累计净流出129万元,其中净流出天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403251616168b6032e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403251616168b6032e3&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sihuanpharm.com.cn","stockEarnings":[{"period":"1week","weight":-0.0192},{"period":"1month","weight":-0.1207},{"period":"3month","weight":-0.1053},{"period":"6month","weight":-0.1639},{"period":"1year","weight":-0.3462},{"period":"ytd","weight":-0.2154}],"compareEarnings":[{"period":"1week","weight":-0.0298},{"period":"1month","weight":-0.0193},{"period":"3month","weight":0.0598},{"period":"6month","weight":-0.0552},{"period":"1year","weight":-0.2046},{"period":"ytd","weight":-0.0483}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"四环医药控股集团有限公司是一家从事药品业务的香港投资控股公司。该公司主要在中国从事研发、制造及销售药品。其产品覆盖心脑血管、中枢神经系统、新陈代谢、肿瘤及抗感染领域。其心脑血管产品包括克林澳、安捷利及欧迪美等。其非心脑血管产品包括仁澳、甲硝唑及罗沙替丁等。","yearOnYearQuotes":[{"month":1,"riseRate":0.615385,"avgChangeRate":0.124332},{"month":2,"riseRate":0.571429,"avgChangeRate":0.002088},{"month":3,"riseRate":0.357143,"avgChangeRate":-0.025475},{"month":4,"riseRate":0.461538,"avgChangeRate":0.02082},{"month":5,"riseRate":0.416667,"avgChangeRate":-0.001685},{"month":6,"riseRate":0.583333,"avgChangeRate":-0.004012},{"month":7,"riseRate":0.5,"avgChangeRate":-0.008059},{"month":8,"riseRate":0.416667,"avgChangeRate":-0.027927},{"month":9,"riseRate":0.083333,"avgChangeRate":-0.082523},{"month":10,"riseRate":0.583333,"avgChangeRate":0.030986},{"month":11,"riseRate":0.538462,"avgChangeRate":0.020616},{"month":12,"riseRate":0.461538,"avgChangeRate":-0.01024}],"exchange":"SEHK","name":"四环医药","nameEN":"SIHUAN PHARM"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"四环医药(00460)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供四环医药(00460)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"四环医药,00460,四环医药股票,四环医药股票老虎,四环医药股票老虎国际,四环医药行情,四环医药股票行情,四环医药股价,四环医药股市,四环医药股票价格,四环医药股票交易,四环医药股票购买,四环医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"四环医药(00460)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供四环医药(00460)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}